Finally, the study demonstrated that treatment with the VDAC1 oligomerization apoptosis and mitochondria dysfunction inhibitor, VBIT-4, reduces atrial fibrosis in the setting of hyperaldosteronism. This evidence concerns the gene VDAC1 and hyperaldosteronism.